🇺🇸 Remimazolam besylate and low-dose Esketamine in United States

Remimazolam besylate and low-dose Esketamine (Remimazolam besylate and low-dose Esketamine) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Remimazolam besylate and low-dose Esketamine in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Remimazolam besylate and low-dose Esketamine approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Remimazolam besylate and low-dose Esketamine in United States?

Second Affiliated Hospital of Wenzhou Medical University is the originator. The local marketing authorisation holder may differ — check the official source linked above.